Skip to main content

Table 2 Distributions of the TNF-α genotypes and alleles among patients and controls

From: The role of Tumor necrosis factor alpha −308 G>A promoter polymorphism in pediatric community acquired pneumonia

 

Patients (n = 45)

Control (n = 45)

OR (95% CI)

p value

Genotype model

 AA

4 (8.9%)

2 (4.4%)

1.6 (0.27–9.25)

0.61

0.012a

 AG

2 (4.4%)

12 (26.7%)

0.13 (0.03–0.63)

 GG

39 (86.7%)

31 (68.9%)

Reference

Dominant model

 GG

39 (86.7%)

31 (68.9%)

Reference

0.048a

 AA+AG

6 (13.3%)

14 (31.1%)

0.34 (0.12–0.99)

Recessive model

 AA

4 (8.9%)

2 (4.4%)

2.09 (0.36–12.07)

0.4

 AG+GG

41 (91.1%)

43 (95.6%)

Reference

Alleles

 A

10 (11.1%)

16 (17.7%)

0.58 (0.25–1.35)

0.21

 G

80 (88.8%)

74 (82.2%)

Reference

  1. Data is expressed a number (percentage)
  2. OR odds ratio, 95% CI confidence interval
  3. aStatistically significant